| #114 |
Tania Ivens |
Biocartis, Nv |
1 |
| #114 |
Francesca PARIS |
Cochlear Limited |
1 |
| #114 |
Pascale Holemans |
Biocartis, Nv |
1 |
| #114 |
Koen Van Acker |
Biocartis, Nv |
1 |
| #114 |
Kristof Paula A. Lesaffre |
Koniniklijke Philips N.V. |
1 |
| #114 |
Jo Ann Nelissen |
The Chemours Company Fc |
1 |
| #114 |
Vicente Osorio |
Cochlear Limited |
1 |
| #114 |
Kruthik Kumar Sujith Kumar |
Grammer Ag |
1 |
| #114 |
Gert VAN GOMPEL |
Vrije Universiteit Brussel |
1 |
| #114 |
Bram De Craene |
Biocartis, Nv |
1 |
| #114 |
Gert Jules Hector De Wilde |
AbbVie |
1 |
| #114 |
Ward Vancoppenholle |
Samsonite Ip Holdings S.A R.L. |
1 |
| #114 |
Nadia Van Geel |
Materialise N.V. |
1 |
| #114 |
Philip M. R. Van Den Broecke |
Cerestar Holding B.V. |
1 |
| #114 |
Frank De Smet |
K.U. Leuven Research & Development |
1 |
| #114 |
Thomas Stainsby |
Cochlear Limited |
1 |
| #114 |
Sebastiaan DE BACKER |
— |
1 |
| #114 |
Dave De Meyer |
Sdl Netherlands B.V. |
1 |
| #114 |
Amanda Sparkes |
Vib Vzw |
1 |
| #114 |
Katrien Geeraerts |
Cochlear Limited |
1 |
| #114 |
Piet Wigernick |
Galapagos Nv |
1 |
| #114 |
Sara Alassia |
Katholieke Universiteit Leuven, Ku Leuven R&D |
1 |
| #114 |
Caroline Jans |
Biocartis, Nv |
1 |
| #114 |
Bruno Van De Pol |
The Procter & Gamble |
1 |
| #114 |
Raf Moens |
E.I. Du Pont De Nemours And |
1 |
| #114 |
Kristine Debruyne |
Cochlear Limited |
1 |
| #114 |
Jörg Kurt Wegner |
Johnson & Johnson |
1 |
| #114 |
Emmanuel VANDER POORTEN |
Katholieke Universiteit Leuven |
1 |
| #114 |
Jörg Kurt Wegner |
Tibotec Pharmaceuticals |
1 |
| #114 |
Joos Dieter |
St-Ericsson Sa |
1 |
| #114 |
Dirk Vermeylen |
Agfa-Gevaert Nv |
1 |
| #114 |
Nadia Otto |
Framatome Connectors International |
1 |